1. Home
  2. GIII vs COLL Comparison

GIII vs COLL Comparison

Compare GIII & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo G-III Apparel Group LTD.

GIII

G-III Apparel Group LTD.

HOLD

Current Price

$29.82

Market Cap

1.3B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.52

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIII
COLL
Founded
1956
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1989
2015

Fundamental Metrics

Financial Performance
Metric
GIII
COLL
Price
$29.82
$45.52
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$31.20
$51.50
AVG Volume (30 Days)
506.8K
481.4K
Earning Date
12-09-2025
02-26-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
3.27
1.63
Revenue
$3,025,059,000.00
$757,067,000.00
Revenue This Year
N/A
$26.35
Revenue Next Year
N/A
$3.67
P/E Ratio
$9.26
$30.01
Revenue Growth
N/A
26.34
52 Week Low
$20.33
$23.23
52 Week High
$34.83
$50.79

Technical Indicators

Market Signals
Indicator
GIII
COLL
Relative Strength Index (RSI) 49.67 42.40
Support Level $29.17 $44.51
Resistance Level $30.71 $49.17
Average True Range (ATR) 0.92 1.66
MACD -0.14 -0.48
Stochastic Oscillator 40.53 10.04

Price Performance

Historical Comparison
GIII
COLL

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenues from Wholesale operations.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: